Medigus Signed a Binding Letter of Intent with Polyrizon for an Investment in and Joint Commercialization of Biological Gels for Protecting Patients against COVID-19 and Other Biological Threats
OMER, Israel, April 24, 2020 (GLOBE NEWSWIRE) — Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a technology company developing minimally invasive tools and […]